pharmaceuticals
The alliance aims to improve gBRCA identification and increase entry to new treatment options.
The new office will support the firm’s plans for advanced injection, wearable devices and connected health technologies.
A new report from PwC predicts that new and proposed FDA regulations could open up doors for pharmaceutical companies looking to develop digital tools.